{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:00:32Z","timestamp":1782219632730,"version":"3.54.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"am","delay-in-days":317,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.trim.2019.101227","type":"journal-article","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T11:34:05Z","timestamp":1563968045000},"page":"101227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications"],"prefix":"10.1016","volume":"56","author":[{"given":"Franck-Nicolas","family":"Bardou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Guillaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domitille","family":"Erard-Poinsot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chambon-Augoyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsa","family":"Thimonier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Vallin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Boillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trim.2019.101227_bb0005","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","article-title":"Trends in the management and burden of alcoholic liver disease","volume":"62","author":"Mathurin","year":"2015","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.trim.2019.101227_bb0010","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1111\/j.1600-6143.2006.01360.x","article-title":"Cyclosporin versus tacrolimus as primary immunosuppressant after liver transplantation: a meta-analysis","volume":"6","author":"McAlister","year":"2006","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.trim.2019.101227_bb0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/lt.21803","article-title":"Long-term renal function in liver transplant recipients and impact of immunosuppressive regimens (calcineurin inhibitors alone or in combination with mycophenolate mofetil): the TRY study","volume":"15","author":"Karie-Guigues","year":"2009","journal-title":"Liver Transpl."},{"issue":"10","key":"10.1016\/j.trim.2019.101227_bb0020","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2012.04140.x","article-title":"Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis","volume":"12","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.trim.2019.101227_bb0025","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2165\/00003495-199346040-00009","article-title":"Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation","volume":"46","author":"Peters","year":"1993","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.trim.2019.101227_bb0030","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v22.i1.427","article-title":"Solid, non-skin, post-liver transplant tumors: key role of lifestyle and immunosuppression management","volume":"22","author":"Carenco","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.trim.2019.101227_bb0035","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/lt.25310","article-title":"Longterm risk of solid organ de novo malignancies after liver transplantation: a French national study on 11","volume":"24","author":"S\u00e9r\u00e9e","year":"2018","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/00912700122010429","article-title":"Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients","volume":"41","author":"Venkataramanan","year":"2001","journal-title":"J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0045","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1600-6143.2011.03486.x","article-title":"Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized study","volume":"11","author":"Boudjema","year":"2011","journal-title":"Am. J. Transplant."},{"issue":"32","key":"10.1016\/j.trim.2019.101227_bb0050","doi-asserted-by":"crossref","first-page":"11363","DOI":"10.3748\/wjg.v20.i32.11363","article-title":"Minimizing tacrolimus strategy and long-term survival after liver transplantation","volume":"20","author":"Jia","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.trim.2019.101227_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","article-title":"Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study","volume":"9","author":"Neuberger","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.trim.2019.101227_bb0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/ajt.13018","article-title":"Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship","volume":"15","author":"Carenco","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.trim.2019.101227_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111128","article-title":"The Tacrolimus metabolism rate influences renal function after kidney transplantation","volume":"9","author":"Th\u00f6lking","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2019.101227_bb0070","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12659\/AOT.895898","article-title":"Tacrolimus concentration\/dose ratio is associated with renal function after liver transplantation","volume":"21","author":"Th\u00f6lking","year":"2016","journal-title":"Ann. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0075","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1572-0241.2007.01079.x","article-title":"Negative impact of de novo malignancies rather than alcohol relapse on survival after liver transplantation for alcoholic cirrhosis: a retrospective analysis of 305 patients in a single center","volume":"102","author":"Dumortier","year":"2007","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.trim.2019.101227_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11883-017-0647-0","article-title":"Alcohol and cardiovascular disease: how much is too much?","volume":"19","author":"Toma","year":"2017","journal-title":"Curr. Atheroscler. Rep."},{"issue":"2","key":"10.1016\/j.trim.2019.101227_bb0085","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/j.2040-4603.2015.tb00625.x","article-title":"Alcohol effects on cardiac function","volume":"5","author":"Gardner","year":"2015","journal-title":"Comprehens. Physiol."},{"issue":"1","key":"10.1016\/j.trim.2019.101227_bb0090","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/1874473710801010056","article-title":"Alcohol abuse, immunosuppression, and pulmonary infection","volume":"1","author":"Zhang","year":"2008","journal-title":"Curr. Drug Abuse Rev."},{"issue":"6","key":"10.1016\/j.trim.2019.101227_bb0095","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0100","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3181896278","article-title":"Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence","volume":"248","author":"Vivarelli","year":"2008","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050587","article-title":"Fast Tac metabolizers at risk (\u2212) it is time for a C\/D ratio calculation","volume":"8","author":"Sch\u00fctte-N\u00fctgen","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.trim.2019.101227_bb0110","doi-asserted-by":"crossref","DOI":"10.1038\/srep32273","article-title":"Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation","volume":"6","author":"Th\u00f6lking","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.trim.2019.101227_bb0115","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jhep.2010.12.001","article-title":"Immunosuppression in liver transplant recipients with renal impairment","volume":"54","author":"Duvoux","year":"2011","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.trim.2019.101227_bb0120","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1432-2277.2007.00596.x","article-title":"Long-term results after liver transplantation","volume":"21","author":"Pfitzmann","year":"2008","journal-title":"Transpl. Int."},{"issue":"10","key":"10.1016\/j.trim.2019.101227_bb0125","first-page":"601","article-title":"Medical management of metabolic complications of liver transplant recipients","volume":"12","author":"Barnard","year":"2016","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"issue":"4","key":"10.1016\/j.trim.2019.101227_bb0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.24738","article-title":"Cardiovascular morbidity and mortality after liver transplantation: the protective role of mycophenolate mofetil","volume":"23","author":"D'Avola","year":"2017","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1016\/j.trim.2019.101227_bb0135","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/j.1478-3231.2010.02274.x","article-title":"Cardiovascular risk factors following orthotopic liver transplantation: predisposing factors, incidence and management","volume":"30","author":"Desai","year":"2010","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.trim.2019.101227_bb0140","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/01.TP.0000081399.75231.3B","article-title":"Tacrolimus enhances transforming growth factor-beta1 expression and promotes tumor progression","volume":"76","author":"Maluccio","year":"2003","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.trim.2019.101227_bb0145","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/liv.12758","article-title":"Incidence of solid organ cancers after liver transplantation: comparison with regional cancer incidence rates and risk factors","volume":"35","author":"Carenco","year":"2015","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.trim.2019.101227_bb0150","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jhep.2013.07.012","article-title":"Reduced exposure to calcineurin inhibitors early after liver transplantation prevents recurrence of hepatocellular carcinoma","volume":"59","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.trim.2019.101227_bb0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/TP.0000000000000965","article-title":"Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, Multicenter, open-label phase 3 trial","volume":"100","author":"Geissler","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2019.101227_bb0160","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-Cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.trim.2019.101227_bb0165","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13306","article-title":"Effect of CYP3A5*1 expression on tacrolimus required dose after liver transplantation: a systematic review and meta-analysis","volume":"32","author":"Hendijani","year":"2018","journal-title":"Clin. Transpl."},{"issue":"8","key":"10.1016\/j.trim.2019.101227_bb0170","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/TP.0b013e318263700a","article-title":"Combinational effect of intestinal and hepatic CYP3A5 genotypes on tacrolimus pharmacokinetics in recipients of living donor liver transplantation","volume":"94","author":"Ji","year":"2012","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.trim.2019.101227_bb0175","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.transproceed.2005.02.104","article-title":"Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy","volume":"37","author":"Iwahori","year":"2005","journal-title":"Transplant. Proc."},{"issue":"9","key":"10.1016\/j.trim.2019.101227_bb0180","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2298\/VSP140905005R","article-title":"Tacrolimus concentration\/dose ratio as a therapeutic drug monitoring strategy: the influence of gender and comedication","volume":"72","author":"Rancic","year":"2015","journal-title":"Vojnosanit. Pregl."},{"issue":"4","key":"10.1016\/j.trim.2019.101227_bb0185","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/j.ajkd.2015.10.024","article-title":"Novel once-daily extended-release tacrolimus versus twice-daily tacrolimus in de novo kidney transplant recipients: two-year results of phase 3, double-blind, randomized trial","volume":"67","author":"Rostaing","year":"2016","journal-title":"Am. J. Kidney Dis."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327419300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:59:19Z","timestamp":1760810359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327419300772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":37,"alternative-id":["S0966327419300772"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2019.101227","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus exposure after liver transplantation for alcohol-related liver disease: Impact on complications","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2019.101227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101227"}}